Advanced Proteome Therapeutics Corporation
Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and i… Read more
Advanced Proteome Therapeutics Corporation (APTCF) - Total Liabilities
Latest total liabilities as of April 2023: $84.49K USD
Based on the latest financial reports, Advanced Proteome Therapeutics Corporation (APTCF) has total liabilities worth $84.49K USD as of April 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Advanced Proteome Therapeutics Corporation - Total Liabilities Trend (1997–2022)
This chart illustrates how Advanced Proteome Therapeutics Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Advanced Proteome Therapeutics Corporation Competitors by Total Liabilities
The table below lists competitors of Advanced Proteome Therapeutics Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SKYWORTH DIGITAL (KYW.SG)
STU:KYW
|
Germany | €44.40 Billion |
|
Northern Star Investment Corp III
PINK:NSTC
|
USA | $19.39 Million |
|
Likewise Group PLC
LSE:LIKE
|
UK | GBX67.14 Million |
|
Afastor Corporation
TWO:6707
|
Taiwan | NT$3.95 Billion |
|
SKYWORTH DIGITAL
MU:KYW
|
Germany | €44.40 Billion |
|
Dyna Group International Inc
PINK:DGIX
|
USA | $1.84 Million |
Liability Composition Analysis (1997–2022)
This chart breaks down Advanced Proteome Therapeutics Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -3.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Advanced Proteome Therapeutics Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Advanced Proteome Therapeutics Corporation (1997–2022)
The table below shows the annual total liabilities of Advanced Proteome Therapeutics Corporation from 1997 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-07-31 | $1.49 Million | -49.70% |
| 2021-07-31 | $2.96 Million | +110.89% |
| 2020-07-31 | $1.40 Million | +29.66% |
| 2019-07-31 | $1.08 Million | +0.13% |
| 2018-07-31 | $1.08 Million | +11.41% |
| 2017-07-31 | $969.35K | +59.19% |
| 2016-07-31 | $608.91K | +15.21% |
| 2015-07-31 | $528.52K | -58.17% |
| 2014-07-31 | $1.26 Million | +33.56% |
| 2013-07-31 | $946.04K | +83.38% |
| 2012-07-31 | $515.88K | +95.28% |
| 2011-07-31 | $264.18K | +26.54% |
| 2010-07-31 | $208.77K | +0.00% |
| 2009-07-31 | $208.77K | +8.25% |
| 2008-07-31 | $192.86K | +10.72% |
| 2007-07-31 | $174.20K | +14852.53% |
| 2006-07-31 | $1.17K | -99.15% |
| 2005-07-31 | $137.20K | -95.84% |
| 2004-07-31 | $3.30 Million | -1.21% |
| 2003-07-31 | $3.34 Million | -67.34% |
| 2002-07-31 | $10.23 Million | -8.98% |
| 2001-07-31 | $11.24 Million | +0.39% |
| 2000-07-31 | $11.19 Million | -10.89% |
| 1999-07-31 | $12.56 Million | +13.71% |
| 1998-07-31 | $11.05 Million | +661.37% |
| 1997-07-31 | $1.45 Million | -- |